Transcatheter aortic valve implantation (TAVI) has recently been approved for low
surgical risk patients.
1
Considering that such patients are more likely to engage in active lifestyles, achieving
optimal hemodynamics may significantly impact their quality of life. Although previous
studies using echocardiography at rest have demonstrated that supra-annular self-expandable
valves (SASEVs) (Evolut PRO+, Medtronic, Minneapolis, Minnesota) are associated with
favorable hemodynamics compared with balloon-expandable valves (BEVs) (Sapien 3 Ultra,
Edwards Lifesciences, Irvine, California),
- Popma JJ
- Deeb GM
- Yakubov SJ
- Mumtaz M
- Gada H
- O'Hair D
- Bajwa T
- Heiser JC
- Merhi W
- Kleiman NS
- Askew J
- Sorajja P
- Rovin J
- Chetcuti SJ
- Adams DH
- Teirstein PS
- Zorn 3rd, GL
- Forrest JK
- Tchétché D
- Resar J
- Walton A
- Piazza N
- Ramlawi B
- Robinson N
- Petrossian G
- Gleason TG
- Oh JK
- Boulware MJ
- Qiao H
- Mugglin AS
- Reardon MJ
Evolut Low Risk Trial Investigators
Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients.
Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients.
N Engl J Med. 2019; 380: 1706-1715
2
there is a paucity of data on the hemodynamic performance of these devices during
exertion.
3
,4
Cardiovascular magnetic resonance (CMR) provides a quantitative assessment of ventricular
volumes and flow and can be used to accurately assess patient-specific cardiac responses
to exercise.
- Abdel-Wahab M
- Landt M
- Neumann FJ
- Massberg S
- Frerker C
- Kurz T
- Kaur J
- Toelg R
- Sachse S
- Jochheim D
- Schäfer U
- El-Mawardy M
- Robinson DR
- Richardt G
CHOICE Investigators
5-year outcomes after transcatheter aortic-valve replacement with balloon-expandable versus self-expanding valves: results from the CHOICE randomized clinical trial.
5-year outcomes after transcatheter aortic-valve replacement with balloon-expandable versus self-expanding valves: results from the CHOICE randomized clinical trial.
JACC Cardiovasc Intv. 2020; 13: 1071-1082
3
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients.N Engl J Med. 2019; 380: 1706-1715
- Comprehensive echocardiographic assessment of normal transcatheter valve function.JACC Cardiovasc Imaging. 2019; 12: 25-34
- Evaluation of aortic stenosis using cardiovascular magnetic resonance: a systematic review & meta-analysis.J Cardiovasc Magn Reson. 2020; 22: 45
- 5-year outcomes after transcatheter aortic-valve replacement with balloon-expandable versus self-expanding valves: results from the CHOICE randomized clinical trial.JACC Cardiovasc Intv. 2020; 13: 1071-1082
- Design of the exercise MRI evaluation of HIV-pulmonary arterial hypertension longitudinal determinants (EXALTED) trial.J Cardiovasc Med (Hagerstown). 2017; 18: 888-896
Article Info
Publication History
Published online: July 13, 2022
Received:
April 20,
2022
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2022 Elsevier Inc. All rights reserved.
